RAPT Therapeutics, Inc. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for RAPT Therapeutics, Inc. (RAPT) is 1.57B

According to RAPT Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.57B. This represents a change of 328.29% compared to the average of 367.05M of the last 4 quarters.

RAPT Therapeutics, Inc. (RAPT) Historical Enterprise Value (quarterly & annually)

How has RAPT Enterprise Value performed in the past?

The mean historical Enterprise Value of RAPT Therapeutics, Inc. over the last ten years is 4.27B. The current 1.57B Enterprise Value has changed 3.58% with respect to the historical average. Over the past ten years (40 quarters), RAPT's Enterprise Value was at its highest in in the December 2018 quarter at 14.35B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

RAPT Therapeutics, Inc. (RAPT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RAPT Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RAPT Therapeutics, Inc. (RAPT) Average Enterprise Value

How has RAPT Enterprise Value performed in the past?

The current Enterprise Value of RAPT Therapeutics, Inc. (RAPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

RAPT Therapeutics, Inc. (RAPT) Enterprise Value vs. Peers

How is RAPT’s Enterprise Value compared to its peers?

RAPT Therapeutics, Inc.’s Enterprise Value is greater than Neumora Therapeutics, Inc. Common Stock (22.47M), greater than Bicycle Therapeutics plc (-241000111.00), greater than Omeros Corporation (1.42B), greater than ADC Therapeutics S.A. (332.82M), greater than Lexicon Pharmaceuticals, Inc. (922.29M), greater than Alumis Inc. (937.96M), greater than Fulcrum Therapeutics, Inc. (244.45M), greater than 4D Molecular Therapeutics, Inc. (736.26M), greater than Gossamer Bio, Inc. (70.92M), greater than KalVista Pharmaceuticals, Inc. (1.49B),

Build a custom stock screener for RAPT Therapeutics, Inc. (RAPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RAPT Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RAPT Therapeutics, Inc. (RAPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RAPT Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.